How long until a buyout?

Quote












No one will touch us, Medivation. There is nothing to gain by buying Medivation. Remember all we have is 50% profit share in US only. Rest of US as well as outside of US belongs to Astellas, our partner. We probably get some very small loyalty.

Unfortunately, if we don't figure out something soon, our share prices will go down even further as more competition may come to market but most of all as we get closer to the date of Abiraterone going generic, on 2017. At that time, we become worthless as no payor will pay for our drug when there is an almost generic drug that does the same thing will do the job. This is the fact that is already happening in outside of US for Oncology drugs in same situation.

Our management does not care as they are already millionaires and they drop their last shares by 2017.

Time to look elsewhere.
 






Anonymous said:
No one will touch us, Medivation. There is nothing to gain by buying Medivation. Remember all we have is 50% profit share in US only. Rest of US as well as outside of US belongs to Astellas, our partner. We probably get some very small loyalty.

Unfortunately, if we don't figure out something soon, our share prices will go down even further as more competition may come to market but most of all as we get closer to the date of Abiraterone going generic, on 2017. At that time, we become worthless as no payor will pay for our drug when there is an almost generic drug that does the same thing will do the job. This is the fact that is already happening in outside of US for Oncology drugs in same situation.

Our management does not care as they are already millionaires and they drop their last shares by 2017.

Time to look elsewhere.
Click to expand...


But you have DS...he will surely save you. :~)
 






Top Bottom
Back
Quote